To continue getting breaking news and the full stories from The Boston Globe, subscribe today.

The Boston Globe

Business

Boston.com

Boston capital

Idenix now in the hunt

By Steven Syre

 |  Globe Columnist  

  January 20, 2012

Just last year, Vertex Pharmaceuticals Inc. of Cambridge and Merck & Co. began selling new drugs that dramatically improved the treatment of patients with hepatitis C. Now another group of companies with a different biotech strategy are preparing a new generation of treatments that show even greater promise. Pharmaceutical giants have spent billions snapping up two of those companies in recent months. Will Idenix Pharmaceuticals Inc. of Cambridge be next?

Stay with the story. Get full access to BostonGlobe.com for just 99¢

Unlimited access to BostonGlobe.com for only 99¢ for the first 4 weeks. You can cancel at any time.

  • The FULL story all day: Enjoy all of the high-quality, in-depth journalism in the print edition of the Boston Globe — plus breaking news that's updated 24/7.
  • A truly reader-friendly format: It's online news that looks and reads just like the newspaper — uncluttered, uninterrupted.
  • Breakthrough technology: The responsive design automatically adapts content so it always reads perfectly on the digital device of your choice.
Get started today

Free access for home delivery subscribers.

Just need to link your home delivery account; one easy step.

Link my home delivery account

BostonGlobe.comSubscriber Log In

Contact us for help